3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
2
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
10
Esophageal Neoplasms
5
Colorectal Neoplasms
5
Rectal Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma Of Esophagus
4
Sarcoma
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neoplasms
2
Melanoma
2
Vomiting
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Nausea
1
Multiple Myeloma
1
Malignant mesenchymal tumor
1
Interventions
Temozolomide
52
Radiotherapy
24
Bevacizumab
23
Radiation
10
Magnetic Resonance Spectroscopy
7
Lomustine
7
Carmustine
7
Radiosurgery
6
Surgical Procedures, Operative
5
Irinotecan
5
Aminolevulinic Acid
5
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Ipilimumab
4
Erlotinib Hydrochloride
4
Cilengitide
4
vocimagene amiretrorepvec
3
vitespin
3
sargramostim
3
poly ICLC
3
pembrolizumab
3
fluoromisonidazole
3
carmustine, poliferprosan 20 drug combination
3
Vorinostat
3
TPI-287
3
O(6)-benzylguanine
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Flucytosine
3
Dynamic Contrast Enhanced Magnetic Resonance Imaging
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Glioblastoma
×
Neoadjuvant Therapy
×
Clear all
NCT04209790
2025-11-10
NeoGlio
Geisinger Clinic
Phase 2
Terminated
2 enrolled
7 charts